This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
J. C. Penney Company
Eades, Kenneth M.; Glazer, David; Eyal, ShacharCase DARDEN-F-1720-EFinanceThe case examines the liquidity issues that J. C. Penney (JCP) experienced in 2012 and 2013 following a decline in sales and profits over several years. Although JCP had been a highly profitable and growing company, the increasing pressures of competition led to changes in strategy and in management that were insufficient to recapture the consistent financial results it had previously enjoyed. While sales and profits waned, the cash balance also ...Starting at €8.20
-
Tamara's New House (C)
Eades, Kenneth M.; Fairchild, Gregory B.; Sinclair, SafiyaCase DARDEN-F-1888-EFinanceThis case series simulates the quintessential “American dream:” buying and financing your first house. For most people, buying a house is the largest purchase they will experience in their lifetime. The process has both legal and economic components, and often requires that the buyer rely heavily upon a realtor to navigate all the technicalities. Along the way, the buyer may experience an emotional roller coaster with both the excitement of becom...Starting at €5.74
-
J. C. Penney Company - Teaching Note
Eades, Kenneth M.Teaching Note DARDEN-F-1720TN-EFinanceTeaching note for product F-1720Starting at €0.00
-
dcs plus: Romanian SaaS Firm Goes International - Teaching Note
Phillip C. NellTeaching Note IVEY-8B20M173-EStrategyTeaching Note for product 9B20M173.Starting at €0.00
-
dcs plus: Romanian SaaS Firm Goes International
Phillip C. NellCase IVEY-9B20M173-EEntrepreneurship, StrategyOn a cold Monday morning in January 2018, the founder and chief executive officer of dcs plus was sitting in a taxi on his way to catch a plane to Dubai, United Arab Emirates. In Dubai, he would be visiting the Middle East subsidiary of his company, a RomStarting at €8.20
-
Pfizer and the Challenges of the Pharmaceutical Industry (A)
Renate Kratochvil; Phillip C. NellCase IVEY-9B19M076-EStrategyIn 2018, President of the United States, Donald Trump, criticized the company Pfizer Inc. (Pfizer) for increasing drug prices—which had been a strategic move by Pfizer in response to industry-wide challenges. This announcement highlighted the complex dynaStarting at €8.20
-
Pfizer and the Challenges of the Pharmaceutical Industry (A) - Teaching Note
Renate Kratochvil; Phillip C. NellTeaching Note IVEY-8B19M076-EStrategyTeaching note for product 9B19M076.Starting at €0.00
-
Pfizer and the Challenges of the Pharmaceutical Industry (B) - Teaching Note
Renate Kratochvil; Phillip C. NellTeaching Note IVEY-8B19M077-EStrategyTeaching Note to accompany product 9B19M077.Starting at €0.00
-
Pfizer and the Challenges of the Pharmaceutical Industry (B)
Renate Kratochvil; Phillip C. NellCase IVEY-9B19M077-EStrategyCase B complements Case A, describing pharmaceutical companies’ strategic responses—such as mega-mergers and acquisitions and specialization—to industry-wide global challenges and highlights strategic decisions by Pfizer’s chief executive officers betweenStarting at €5.74
-
Larry Puglia and the T. Rowe Price Blue Chip Growth Fund
Eades, Kenneth M.; Kelly, Dorothy C.Case DARDEN-F-1772-EFinanceSet in late 2016, this case recounts the remarkable performance record of Blue Chip Growth Fund (BCGF), a mutual fund managed by Larry Puglia at T. Rowe Price, Inc. The case describes the investment style of Puglia, whose record with BCGF had on average outperformed the S&P 500 since the inception of the fund in 1993. The tasks for the student are to assess the performance of the fund, consider the sources of its success, and decide on the sustai...Starting at €8.20